02006oam 2200421 a 450 991069994250332120110118113352.0(CKB)5470000002406532(OCoLC)651817041(EXLCZ)99547000000240653220100802d2010 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierEnd-stage renal disease[electronic resource] CMS should monitor access to and quality of dialysis care promptly after implementation of new bundled payment system : report to congressional requesters[Washington D.C.] :U.S. Govt. Accountability Office,[2010]1 online resource (iii, 66 pages) illustrations, chartsTitle from PDF title screen (GAO, viewed July 8, 2010)."March 2010.""GAO-10-295."Includes bibliographical references.Letter--Appendix I objectives, scope, and methodology--Appendix II GAO data collection instrument on dose of dialysis related drugs--Appendix III Medicare expenditures for injectable ESRD drugs by demographic characters--Appendix IV detailed results from data collection instrument on dose of dialysis-related drugs--Appendix V comments from the centers of Medicare & Medicaid services--Appendix VI GAO contact and staff acknowledgments--Tables--Figures.End-stage renal disease HemodialysisPatientsEconomic aspectsHemodialysisPatientsMedical careGovernment policyUnited StatesMedicareEconomic aspectsHemodialysisPatientsEconomic aspects.HemodialysisPatientsMedical careGovernment policyMedicareEconomic aspects.VVKVVKGPOBOOK9910699942503321End-stage renal disease3440710UNINA